Selectquote released FY2025 Q4 earnings on August 21 Pre-Market (EST), actual revenue USD 345.1 M (forecast USD 334.09 M), actual EPS USD -0.0211 (forecast USD -0.2033)
Brief Summary
Selectquote reported Q4 2025 earnings with revenue of $345.102 million, exceeding the expected $334.086 million, and an EPS of -$0.0211, better than the forecasted -$0.2033 Benzinga.
Impact of The News
Financial Overview
Revenue Performance: Selectquote’s revenue for Q4 2025 was $345.102 million, surpassing analyst expectations of $334.086 million Benzinga+ 2. This indicates strong sales, primarily driven by increased pharmacy income, which rose from $144.55 million to $210.6 million compared to the previous year rttnews.
Earnings Per Share (EPS): The company reported an EPS of -$0.0211, significantly better than the anticipated loss of -$0.2033 per share, showcasing an improvement in financial efficiency Benzinga.
Adjusted EBITDA: The adjusted EBITDA was reported at $126 million with a margin of 8%, indicating robust operational performance Motley Fool.
Market Expectations and Comparisons
- Market Performance: Selectquote’s actual EPS and revenue figures beat the prior expectations, resulting in a sharp rise in stock price by 40.5% during morning trading Benzinga.
Business Status and Trends
Growth Trajectory: The leap in pharmacy revenue indicates a strategic focus and potential growth area for Selectquote rttnews.
2026 Fiscal Year Outlook: The company has issued optimistic revenue guidance for 2026, projecting between $1.65 billion to $1.75 billion, which surpasses analysts’ average expectation of $1.7 billion rttnews.
Stock Market Reaction: The better-than-expected financial results have positively impacted investor sentiment, leading to a significant increase in stock price, which could continue if future projections align with actual performance Benzinga.
